to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
DioGenix, in Gaithersburg, Md., was founded in 2009 after CEO Larry Tiffany and his senior management team saw a clear clinical need: monitoring disease progression of multiple sclerosis (MS). Tiffany has an extensive background in biotech, as an IP attorney, and as a senior executive at small and mid-size biotech companies. Before DioGenix, he was senior vice president and general manager of genomics for another genomics research company, Gene Logic.
At the 2012 Health Innovation Summit, entrepreneurs offered advice to medical companies for designing successful new health apps and devices.
Some medical device sales strategies that worked in the past are not recommended now. Read more for alternatives to boost sales for medical device startups.
Getting a CE Mark in Europe has allowed American medical device makers to commercialize quickly before getting U.S. Food and Drug Administration approval to sell medical devices domestically. Read about how the less stringent European regulation methods are now being questioned.
An emerging health IT startup in Ohio landed an international deal in Canada that forced it – and gave it a reason – to make its electronic health record software multilingual.
Ideas for healthcare innovations abound, but will go nowhere unless entrepreneurs with defined goals and healthcare business plans bring those ideas to life.
Being in the healthcare business is getting tougher when it comes to bringing innovative products to market. A recent conference included discussions about some of the challenges that medical innovators are facing today.
Medical device startups may need an alternate strategy to address the coming changes resulting from an increased emphasis on wellness. Read more for tips.
One way for life science and digital health entrepreneurs to innovate: turn landmark literature into accessible, web-based programs.
That’s what Omada Health, a San Francisco startup, has done for diabetes prevention. In a session on the future of intervention at the FutureMed conference at Singularity University in the Silicon Valley last week, the company’s co-founder and CEO Sean Duffy explained the effort.
What's in a name? Read one medical business and marketing consultant's take on the conflicting demands of naming medical technology and medical device startups.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
© 2013 Ewing Marion Kauffman Foundation. All Rights Reserved.